LEAD PB-212 OXOREOTIDE ATEXETAN CITRATE
UNII QT9626FW9Q

Substance Identification & Data

This profile provides standardized clinical and technical data for Lead Pb-212 Oxoreotide Atexetan Citrate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) QT9626FW9Q.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3098765-13-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

QT9626FW9Q

CAS Registry Number

3098765-13-7

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

LEAD PB-212 OXOREOTIDE ATEXETAN CITRATE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C65H92N17O16S2.C6H7O7.Pb

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

XLOSKLHAGZDGEI-SWLMXVKESA-L

Line notation for describing the chemical structure and connectivity of atoms.

INN ID

14206

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

NO-67

Identifier assigned by the United States Adopted Names Council.

Substance Type

Lead Pb-212 Oxoreotide Atexetan Citrate

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C(c1c2c([nH]c1)cccc2)[C@H]3NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@@H](NC([C@@H](Cc5ccccc5)NC(CN6CCN(CC(N)=O)CCN(CC(N)=O)CCN(CC(N)=O)CC6)=O)=O)CSSC[C@@H](C(N[C@@H]([C@@H](C)O)C([O-])=O)=O)NC(=O)[C@]([C@@H](C)O)(NC(=O)[C@H](CCCCN)NC3=O)[H].[212Pb+2].OC(C([O-])=O)(CC(O)=O)CC(O)=O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Lead Pb-212 Oxoreotide Atexetan Citrate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

Lead Pb-212 Oxoreotide Atexetan Citrate

Common Names & Synonyms

DOTAMTATE LEAD PB-212 CITRATE

DOTAMTATE PB-212 CITRATE

LEAD PB 212 OXOREOTIDE ATEXETAN CITRATE [USAN]

LEAD-212 DOTAMTATE CITRATE

Systematic Nomenclature

Lead(1+)-212Pb, [N-[2-[4,7,10-tris[2-amino-2-(oxo-κO)ethyl]-1,4,7,10-tetraazacyclododec-1-yl-κN1,κN4,κN7,κN10]acetyl-κO]-D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-threonyl-L-cysteinyl-L-threonine cyclic (2→7)-disulfidato]-, hydrogen 2-hydroxy-1,2,3-propanetricarboxylate (1:2:1)

SYS

Technical Codes

212Pb-DOTAM-(Tyr3)-Octreotate;

212Pb-DOTAMTATE

External Clinical & Regulatory Resources

Previous UNIIQT9515X0WW

Next UNIIQT9D7W9SX6